GlassScriptPhysician profile
Edward Melton Mcintire
NPI 1184689788
$6,924.35
in general payments reported to CMS, 2019-2025
31 companies · $3,147 in 2025
The $3,147 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $54.23 · 2021: $15.88 · 2022: $290 · 2023: $1,462 · 2024: $1,850 · 2025: $3,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,838 · Consulting Fee: $1,880 · Travel and Lodging: $1,665 · Education: $75.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,837.89 |
| Consulting Fee | $1,880.00 |
| Travel and Lodging | $1,664.66 |
| Education | $75.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,136.96 | 2023-2025 | Erleada |
| Procept Biorobotics Corporation | $1,157.31 | 2024-2025 | Aquabeam System |
| Teleflex LLC | $971.38 | 2022-2025 | Urolift, Barrigel |
| Urogen Pharma, INC. | $322.42 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $322.12 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $288.83 | 2022-2025 | |
| Pfizer INC. | $275.44 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $232.50 | 2023-2025 | Prolaris, Myrisk |
| Sumitomo Pharma America, INC. | $173.80 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $158.86 | 2019-2024 | Xtandi |
| Boston Scientific Corporation | $117.61 | 2022-2025 | General - Male Sui, Tria Firm, Solyx Sis System |
| Astrazeneca Pharmaceuticals LP | $93.99 | 2023-2025 | Lynparza, Imfinzi |
| Laborie Medical Technologies Corp. | $83.75 | 2021-2025 | Optilume Bph Drug Coated Balloon Catheter, Eclipse |
| Abbvie INC. | $71.47 | 2019-2024 | |
| Calyxo, INC. | $66.80 | 2025 | Cvac Aspiration System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $64.28 | 2023-2024 | |
| Medtronic, INC. | $60.28 | 2023 | Interstim |
| Novartis Pharmaceuticals Corporation | $44.83 | 2025 | |
| Photocure INC | $41.00 | 2025 | Cysview |
| Accord Healthcare, INC. | $39.32 | 2025 | |
| Tempus Ai, INC | $28.51 | 2024 | Xt Cdx |
| Blue Earth Diagnostics | $26.45 | 2023 | |
| Merck Sharp & Dohme LLC | $24.50 | 2025 | Keytruda |
| Ferring Pharmaceuticals INC. | $23.86 | 2024 | Adstiladrin |
| Sun Pharmaceutical Industries INC. | $18.71 | 2024 | |
| Angiodynamics, INC. | $18.01 | 2024 | Nanoknife |
| Endo Pharmaceuticals INC. | $17.84 | 2024 | Aveed, Xiaflex |
| Olympus America INC. | $14.99 | 2025 | Itind System |
| Neotract INC. | $12.72 | 2020 | |
| Medtronic USA, INC. | $11.99 | 2019 | |
| Travere Therapeutics, INC. | $3.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Mcintire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.